Agilent Technologies, Inc. $A Shares Sold by Nordea Investment Management AB

Nordea Investment Management AB lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 41.5% during the 3rd quarter, Holdings Channel reports. The fund owned 1,880,440 shares of the medical research company’s stock after selling 1,333,308 shares during the quarter. Nordea Investment Management AB’s holdings in Agilent Technologies were worth $235,469,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. Forum Financial Management LP increased its position in Agilent Technologies by 2.5% during the third quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock worth $375,000 after purchasing an additional 70 shares during the last quarter. Wedmont Private Capital grew its stake in shares of Agilent Technologies by 2.3% in the 3rd quarter. Wedmont Private Capital now owns 3,630 shares of the medical research company’s stock valued at $503,000 after buying an additional 81 shares during the period. waypoint wealth counsel increased its holdings in shares of Agilent Technologies by 4.3% during the 3rd quarter. waypoint wealth counsel now owns 1,984 shares of the medical research company’s stock worth $255,000 after buying an additional 82 shares during the last quarter. Verdence Capital Advisors LLC raised its position in shares of Agilent Technologies by 5.0% during the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock valued at $215,000 after buying an additional 86 shares during the period. Finally, M&T Bank Corp lifted its holdings in Agilent Technologies by 0.4% in the second quarter. M&T Bank Corp now owns 23,205 shares of the medical research company’s stock valued at $2,738,000 after acquiring an additional 86 shares during the last quarter.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the sale, the chief executive officer owned 32,058 shares in the company, valued at $4,591,987.92. This represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 16,401 shares of company stock worth $2,468,962 in the last ninety days.

Agilent Technologies Stock Performance

NYSE A opened at $146.47 on Wednesday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The company has a market cap of $41.52 billion, a P/E ratio of 32.05, a P/E/G ratio of 4.30 and a beta of 1.29. The stock has a 50-day moving average of $144.62 and a two-hundred day moving average of $133.04. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be paid a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s payout ratio is presently 22.32%.

Analysts Set New Price Targets

A number of research firms have commented on A. Wells Fargo & Company lifted their target price on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Morgan Stanley started coverage on Agilent Technologies in a research report on Tuesday, December 2nd. They set an “overweight” rating for the company. Barclays raised shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 target price on the stock in a research report on Monday, December 15th. The Goldman Sachs Group started coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price target for the company. Finally, Robert W. Baird boosted their price target on shares of Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research note on Tuesday, November 25th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $163.31.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.